abemaciclib monotherapy’s role in hr breast cancer
Published 6 years ago • 325 plays • Length 4:45Download video MP4
Download video MP3
Similar videos
-
5:06
monarch 1: abemaciclib monotherapy for hr mbc
-
1:39
dr. ellis on abemaciclib in hr-positive breast cancer
-
7:09
abemaciclib for hr-positive metastatic breast cancer
-
3:26
emerging role of abemaciclib for hr advanced breast cancer
-
1:12
monarche: adjuvant abemaciclib in hr breast cancer
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
1:41
dr. harold j. burstein on cdk4/cdk6 inhibitor abemaciclib in breast cancer
-
1:18
findings with abemaciclib plus tamoxifen in advanced breast cancer
-
9:18
monarch 3: abemaciclib with endocrine therapy for mbc
-
3:09
dr mouabbi on the use of ribociclib vs abemaciclib in hr /her2– breast cancer
-
1:41
postmonarch: abemaciclib with fulvestrant in pretreated hr /her2- breast cancer
-
0:53
postmonarche: abemaciclib fulvestrant in hr /her2- mbc following cdk4/6i & endocrine therapy
-
1:19
advantages to treating hr patients with breast cancer with abemaciclib
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
5:04
abemaciclib fulvestrant at progression of hr mbc
-
0:22
copy of dr. ellis on abemaciclib in hr-positive breast cancer
-
6:15
abemaciclib with hormone therapy for hr mbc
-
7:17
abemaciclib for er mbc